Breaking Stories

Citi says buy the dip in Eli Lilly ahead of Alzheimer’s drug launch

Eli Lilly Pharmaceutical company logo

SOPA Images | LightRocket | Getty Images

The recent pullback in Eli Lilly’s stock provides an attractive buying opportunity ahead of the pharmaceutical company’s Alzheimer’s drug launch, Citi said.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *